RESOURCES & PERSPECTIVES
-
Optimal COA Measurement Strategy In Modern Oncology Trials
8/29/2023
Consider these factors when contemplating an ideal Clinical Outcome Assessment measurement strategy while incorporating patient-reported outcome measures in oncology investigations.
-
EMA Paper Overview: Decentralized Elements In Clinical Trials
8/29/2023
Review a summary of themes highlighted from the recent EMA recommendation paper concerning decentralized components within regulatory submissions for clinical trials.
-
What 4 Things Do All eCOA Studies Need To Succeed?
8/8/2023
Learn what else, in addition to good technology, study teams need for eCOA studies to succeed.
-
3 Themes And Takeaways From FDA’s Draft Guidance On DCTs
8/8/2023
Get our experts’ summary of recent regulatory guidance as well as recommendations for optimal decentralized clinical trial design and conduct.
-
Computerized Adaptive Tests Using PROMIS CAT
8/8/2023
Learn how Signant’s unique PROMIS CAT captures high-quality COA data while reducing completion burden.
-
Increase Participant Diversity With eClinical Tools
4/14/2023
The right technology and community partnerships can help sponsors meet FDA diversity requirements without additional expenditures, build relationships with minorities, and prepare for future trials.
-
Finally, A Unified eClinical Platform With One Login
4/10/2023
Make hybrid and decentralized clinical trials expedient and cost-effective, without time-consuming integrations, lengthy start-up times, or specialized staff with unified eClinical solutions.
-
The New Industry Migration Framework For FSP
2/28/2023
Review why a functional service provider should be on the top of a sponsor’s list when it comes to choosing a specialized eClinical data management provider for its next study.
-
FDA Guidance Has Implications For EDC And EHR eSource Capabilities
2/28/2023
Gain insight from an eSource study observing digitally received data as far back as 2007 to just before initial guidance was released by the U.S. FDA in 2013.